Publicações

A Multicenter, Open-Label, Randomized, Phase Iii Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician's Choice in Patients with Advanced Endometrial Cancer

AuthID
P-00V-T9W

Author(s)

Makker, V

Colombo, N

Herráez, AC

Santin, A

Colomba, E

Miller, D

Fujiwara, K

Pignata, S

Baron-Hay, S

Ray-Coquard, I

[+4]·

Kim, YM

Guerra, E

Sanli, U

McCormack, M

Huang, J

Smith, A

Keefe, S

Dutta, L

Orlowski, R

Lorusso, D

View all authors

Tipo de Documento

Article

Year published

2021

Publicado

in Gynecologic Oncology, ISSN: 0090-8258

Volume: 162, Páginas: S4

Indexing

Crossref^®27

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/s0090-8258(21)00657-0

Source Identifiers

ISSN: 0090-8258

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Makker, V;	2	Colombo, N;	3	Herráez, AC;
4	Santin, A;	5	Colomba, E;	6	Miller, D ;
7	Fujiwara, K;	8	Pignata, S;	9	Baron-Hay, S;
10	Ray-Coquard, I;	11	Shapira-Frommer, R;	12	Ushijima, K;
13	Sakata, J;	14	Yonemori, K;	15	Kim, YM;
16	Guerra, E;	17	Sanli, U;	18	McCormack, M;
19	Huang, J;	20	Smith, A;	21	Keefe, S;
22	Dutta, L;	23	Orlowski, R;	24	Lorusso, D;

A Multicenter, Open-Label, Randomized, Phase Iii Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician's Choice in Patients with Advanced Endometrial Cancer

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

A Multicenter, Open-Label, Randomized, Phase Iii Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician's Choice in Patients with Advanced Endometrial Cancer

Links Úteis

Ajuda